[11C]PS13

N/A

Report date: 2022/12/09 19:21:46
NME

Base Information

Drug Name[11C]PS13
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Post-Acute COVID-19 SyndromeCognitive Dysfunction +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Mental Health
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Mental HealthNational Institute Of Mental Health (Nimh)
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Post-Acute COVID-19 SyndromeCognitive Dysfunction +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A